Indeed, it is known that in the postmenopausal period that low ADPN plasma levels are associated with an increased prevalence of metabolic syndrome, osteoporosis, and obesity [92]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.